Apyx Medical Corp Investment Income, Interest
Apyx Medical Corp (APYX) reported Investment Income, Interest of $250.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- Apyx Medical Corp investment income, interest for the quarter ending 2026-06-30 was $250.00K, a 10.07% decline year-over-year.
- Apyx Medical Corp investment income, interest for the quarter ending 2026-03-31 was $244.00K, a 19.74% decline year-over-year.
- Apyx Medical Corp investment income, interest for the quarter ending 2025-12-31 was $234.00K, a 20.41% decline year-over-year.
- Apyx Medical Corp investment income, interest for the quarter ending 2025-09-30 was $292.00K, a 22.75% decline year-over-year.
- Apyx Medical Corp investment income, interest for fiscal 2025 was $1.11M, a 31.01% decline from fiscal 2024.
- Apyx Medical Corp investment income, interest for fiscal 2024 was $1.61M, a 74.38% increase from fiscal 2023.
- Apyx Medical Corp investment income, interest for fiscal 2023 was $921.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $250.00K 10-Q · filed 2026-08-06 | $494.00K 10-Q · filed 2026-08-06 | $728.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.02M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $244.00K 10-Q · filed 2026-05-07 | $478.00K derived: sum of 2 quarters · filed 2026-05-07 | $770.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $234.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $526.00K derived: sum of 2 quarters · filed 2026-03-10 | $804.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.11M 10-K · filed 2026-03-10 |
| 2025-09-30 | $292.00K 10-Q · filed 2025-11-06 | $570.00K derived: sum of 2 quarters · filed 2026-08-06 | $874.00K 10-Q · filed 2025-11-06 | $1.17M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $278.00K 10-Q · filed 2026-08-06 | $582.00K 10-Q · filed 2026-08-06 | $876.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $304.00K 10-Q · filed 2026-05-07 | $598.00K derived: sum of 2 quarters · filed 2026-05-07 | $976.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.42M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $672.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.11M derived: sum of 3 quarters · filed 2026-03-10 | $1.61M 10-K · filed 2026-03-10 |
| 2024-09-30 | $378.00K 10-Q · filed 2025-11-06 | $817.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.31M 10-Q · filed 2025-11-06 | $1.75M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $439.00K 10-Q · filed 2025-08-07 | $934.00K 10-Q · filed 2025-08-07 | $1.38M derived: sum of 3 quarters · filed 2025-08-07 | $1.63M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $495.00K 10-Q · filed 2025-05-08 | $938.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.19M derived: sum of 3 quarters · filed 2025-05-08 | |
| 2023-12-31 | $443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $691.00K derived: sum of 2 quarters · filed 2025-03-13 | $921.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $248.00K 10-Q · filed 2024-11-08 | $478.00K 10-Q · filed 2024-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |